News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,000 Results
Type
Article (8062)
Company Profile (150)
Press Release (481788)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166800)
Career Advice (304)
Deals (25747)
Drug Delivery (9)
Drug Development (52877)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238279)
Policy (17928)
Tag
2025 Best Places to Work (5)
2026 Best Places to Work (12)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (502)
Accelerated approval (31)
ADA (18)
Adcomms (1)
Allergies (103)
Alliances (33162)
ALS (123)
Alzheimer's disease (1023)
Antibody-drug conjugate (ADC) (338)
Approvals (10500)
Artificial intelligence (385)
ASCO (160)
Autoimmune disease (261)
Automation (34)
Bankruptcy (264)
Belgium (4)
Best Places to Work (6959)
BIO (36)
Biologics (65)
BIOSECURE Act (1)
Biosimilars (141)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (31)
Bladder cancer (150)
Brain cancer (37)
Breast cancer (556)
Cancer (4163)
Cardiovascular disease (251)
Career advice (245)
Career pathing (1)
CAR-T (196)
CDC (2)
CDMO (37)
Celiac Disease (3)
Cell therapy (538)
Cervical cancer (39)
Clinical research (48665)
Collaboration (1392)
Commercialization (35)
Compensation (1669)
Complete response letters (37)
COVID-19 (780)
CRISPR (75)
C-suite (874)
Cystic fibrosis (90)
Data (6773)
Denatured (4)
Depression (109)
Dermatology (107)
Diabetes (394)
Diagnostics (4291)
Digital health (44)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (178)
Drug pricing (22)
Drug shortages (3)
Duchenne muscular dystrophy (176)
Earnings (74586)
Editorial (2)
Employer branding (2)
Employer resources (14)
ESMO (240)
Events (89304)
Executive appointments (745)
Eye disease (8)
FDA (12757)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (26)
Funding (1012)
Gene editing (140)
Generative AI (15)
Gene therapy (360)
GLP-1 (326)
Government (965)
Grass and pollen (2)
Guidances (288)
Healthcare (9485)
Hematology (115)
HIV (60)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (82)
Immunology and inflammation (117)
Immuno-oncology (75)
Indications (191)
Infectious disease (991)
Inflammatory bowel disease (145)
Inflation Reduction Act (4)
Influenza (90)
Intellectual property (278)
Interviews (41)
IPO (12401)
IRA (3)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (93)
Layoffs (59)
Legal (5206)
Licensing (71)
Liver cancer (47)
Longevity (28)
Lung cancer (591)
Lung diease (11)
Lymphoma (284)
Machine learning (30)
Management (3)
Manufacturing (634)
Marketing (25)
MASH (131)
Medical affairs (2)
Medical device (8733)
Medtech (8936)
Mergers & acquisitions (14506)
Metabolic disorders (808)
mRNA (83)
Multiple sclerosis (119)
Multispecific (4)
NASH (4)
Netherlands (4)
Neurodegenerative disease (250)
Neuropsychiatric disorders (41)
Neuroscience (2001)
Neurotech (2)
NextGen: Class of 2026 (3153)
Non-profit (845)
Obesity (255)
Opinion (10)
Ovarian cancer (185)
Pain (197)
Pancreatic cancer (240)
Parkinson's disease (221)
Partnered (12)
Patents (537)
Patient advocacy (3)
Patient recruitment (550)
Patient selection (56)
Peanut (34)
People (41597)
Peptides (26)
Pharmaceutical (30)
Pharmacy benefit managers (30)
Phase 1 (15714)
Phase 2 (21765)
Phase 3 (14682)
Pipeline (9160)
Policy (26)
Postmarket research (1571)
Preclinical (6625)
Press Release (34)
Prostate cancer (213)
Psychedelics (14)
Radiopharmaceuticals (205)
Rare diseases (643)
Real estate (3026)
Recruiting (6)
Regenerative medicine (18)
Regulatory (15288)
Reports (27)
Research institute (596)
Resumes & cover letters (45)
Rett syndrome (48)
RNA editing (9)
RSV (52)
Schizophrenia (112)
Series A (179)
Series B (129)
Service/supplier (5)
Sickle cell disease (70)
Special edition (1)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2022)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (57)
Switzerland (2)
Tariffs (2)
Vaccines (366)
Venture capital (18)
Weight loss (87)
Wet AMD (3)
Women's health (102)
Date
Today (113)
Last 7 days (564)
Last 30 days (2467)
Last 365 days (19265)
2026 (17499)
2025 (19258)
2024 (23015)
2023 (26542)
2022 (34589)
2021 (37171)
2020 (33480)
2019 (23272)
2018 (17493)
2017 (18768)
2016 (17920)
2015 (24266)
2014 (21687)
2013 (18139)
2012 (20224)
2011 (20444)
2010 (20333)
Location
Africa (233)
Alabama (81)
Alaska (2)
Arizona (332)
Arkansas (12)
Asia (18112)
Australia (2129)
California (13446)
Canada (3469)
China (596)
Colorado (553)
Connecticut (474)
Delaware (238)
Europe (24884)
Florida (2002)
Georgia (423)
Hawaii (3)
Idaho (46)
Illinois (807)
India (67)
Indiana (341)
Iowa (19)
Japan (472)
Kansas (106)
Kentucky (34)
Louisiana (30)
Maine (27)
Maryland (1321)
Massachusetts (8796)
Michigan (327)
Minnesota (623)
Mississippi (5)
Missouri (87)
Montana (20)
Nebraska (11)
Nevada (143)
New Hampshire (61)
New Jersey (2959)
New Mexico (12)
New York (3136)
North Carolina (1417)
North Dakota (4)
Northern California (6831)
Ohio (311)
Oklahoma (15)
Oregon (17)
Pennsylvania (2505)
Puerto Rico (24)
Rhode Island (32)
South America (407)
South Carolina (82)
South Dakota (1)
Southern California (5628)
Tennessee (134)
Texas (2224)
United States (43480)
Utah (407)
Vermont (1)
Virginia (169)
Washington D.C. (41)
Washington State (1024)
West Virginia (1)
Wisconsin (84)
Wyoming (1)
490,000 Results for "caremark inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Arcutis Announces ZORYVE® (Roflumilast) Cream 0.3% Has Been Included in a Preferred Position on National Formularies for CVS Caremark
Arcutis Biotherapeutics, Inc. announced that ZORYVE® cream 0.3% for the treatment of plaque psoriasis, including intertriginous psoriasis in adults and adolescents, is now covered as a preferred tier product on CVS Caremark’s largest national commercial formularies effective July 5.
July 17, 2023
·
5 min read
Press Releases
Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies
May 1, 2025
·
9 min read
Press Releases
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients
July 30, 2024
·
12 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Business
AbbVie’s Humira Continues to Lose Market Share as Biosimilars Gain Ground: Report
CVS Caremark’s recent decision to take AbbVie’s Humira off its major formularies has caused the blockbuster to lose more market share to biosimilars, according to the latest report from Samsung Bioepis.
July 12, 2024
·
2 min read
·
Tristan Manalac
Pharmacy benefit managers
Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster
Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.
August 27, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Mint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in Canada
October 6, 2026
·
3 min read
Pharmacy benefit managers
House Oversight Chair Calls on PBM Execs to Correct Testimonies
The chair of the House Committee on Oversight and Accountability wants the CEOs of CVS Caremark, Express Scripts and Optum Rx to fix statements they made in a hearing last month that contradicted the committee’s and Federal Trade Commission’s findings.
August 29, 2024
·
2 min read
·
Tristan Manalac
Bio NC
Bioventus to Provide CVS Caremark® with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief
Bioventus to Provide CVS Caremark ® with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief
November 10, 2020
·
3 min read
Press Releases
Exicure, Inc. Announces Agreement to Sell GPC-100 Program Assets to GPCRT Inc. for KRW 6.5 Billion
November 10, 2026
·
4 min read
1 of 49,000
Next